These findings were confirmed in the current work as TNF-α, IL-1β, and caspase-3 reactions were reduced in the experimental groups receiving MSCs with the addition that the MT-pre-treated AD- and BM-MSCs revealed normal parameters. The gene discussed is TNF; the disease is Alzheimer disease.